Michael G Backlund, Joseph M Amann, David H Johnson. Show Affiliations »
Abstract
Entities: Chemical Disease
Mesh： See more » Antineoplastic Combined Chemotherapy Protocols/therapeutic useBiomarkers, Tumor/metabolismCarcinoma, Non-Small-Cell Lung/drug therapyCarcinoma, Non-Small-Cell Lung/metabolismCelecoxibCyclooxygenase 2/metabolismCyclooxygenase 2 Inhibitors/therapeutic useEicosanoids/antagonists & inhibitorsEicosanoids/metabolismGene Expression Regulation, Enzymologic/drug effectsGene Expression Regulation, Neoplastic/drug effectsHumansHydroxyurea/analogs & derivativesHydroxyurea/therapeutic useLipoxygenase Inhibitors/therapeutic useLung Neoplasms/drug therapyLung Neoplasms/metabolismPyrazoles/therapeutic useRandomized Controlled Trials as TopicSulfonamides/therapeutic useUp-Regulation
Substances： See more » Biomarkers, TumorCyclooxygenase 2 InhibitorsEicosanoidsLipoxygenase InhibitorsPyrazolesSulfonamidesCyclooxygenase 2CelecoxibzileutonHydroxyurea
Year: 2008 PMID： 18281650 DOI： 10.1200/JCO.2007.14.9583
Source DB: PubMed Journal: J Clin Oncol ISSN： 0732-183X Impact factor: 44.544